Jürgen Bajorath

Prof. Jürgen Bajorath

University of Bonn
+1
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2020 in Chemical Society Reviews
Verified
Journal Article
Open access
PDF file
EMEugene Muratov
Eugene Muratov
Jürgen BajorathJürgen Bajorath
Jürgen Bajorath
RSRobert P. Sheridan
Robert P. Sheridan
Igor V. TetkoIgor V. Tetko
Igor V. Tetko
DFDmitry Filimonov
Dmitry Filimonov
ATAlexander Tropsha
Alexander Tropsha
Word cloud summary of diverse topics associated with QSAR modeling that are discussed in this review.

2 May 2020 in Journal of Computer-Aided Molecular Design
Verified
Journal Article
Open access
PDF file
RRRaquel Rodríguez-Pérez
Raquel Rodríguez-Pérez
Jürgen BajorathJürgen Bajorath
Jürgen Bajorath
Difficulties in interpreting machine learning (ML) models and their predictions limit the practical applicability of and confidence in ML in pharmaceutical research. There is a need for agnostic approaches aiding in the interpretation of ML models regardless of their complexity that is also applicable to deep neural network (DNN) architectures and model ensembles. To these ends, the SHapley Additive exPlanations (SHAP) methodology has recently been introduced. The SHAP approach enables the identification and prioritization of features that determine compound classification and activity prediction using any ML model. Herein, we further extend the evaluation of the SHAP methodology by investigating a variant for exact calculation of Shapley values for decision tree methods and systematically compare this variant in compound activity and potency value predictions with the model-independent SHAP method. Moreover, new applications of the SHAP analysis approach are presented including interpretation of DNN models for the generation of multi-target activity profiles and ensemble regression models for potency prediction.

11 November 2013 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
GMGerald Maggiora
Gerald Maggiora
MVMartin Vogt
Martin Vogt
DSDagmar Stumpfe
Dagmar Stumpfe
Jürgen BajorathJürgen Bajorath
Jürgen Bajorath


21 December 2016 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
YHYe Hu
Ye Hu
DSDagmar Stumpfe
Dagmar Stumpfe
Jürgen BajorathJürgen Bajorath
Jürgen Bajorath

19 March 2022 in Journal of Computer-Aided Molecular Design
Verified
Journal Article
Open access
PDF file
RRRaquel Rodríguez-Pérez
Raquel Rodríguez-Pérez
Jürgen BajorathJürgen Bajorath
Jürgen Bajorath
The support vector machine (SVM) algorithm is one of the most widely used machine learning (ML) methods for predicting active compounds and molecular properties. In chemoinformatics and drug discovery, SVM has been a state-of-the-art ML approach for more than a decade. A unique attribute of SVM is that it operates in feature spaces of increasing dimensionality. Hence, SVM conceptually departs from the paradigm of low dimensionality that applies to many other methods for chemical space navigation. The SVM approach is applicable to compound classification, and ranking, multi-class predictions, and –in algorithmically modified form– regression modeling. In the emerging era of deep learning (DL), SVM retains its relevance as one of the premier ML methods in chemoinformatics, for reasons discussed herein. We describe the SVM methodology including strengths and weaknesses and discuss selected applications that have contributed to the evolution of SVM as a premier approach for compound classification, property predictions, and virtual compound screening.